
ASTHMA
gpatlas.co.uk
π When to Suspect
Episodic wheeze, cough, breathlessness, or chest tightness, often worse at night or with triggers like viral infections, allergens, or exercise
π©Ί Assessment
- β Symptoms + triggers β Episodic wheeze, cough, shortness of breath, chest tightness; triggered by viruses, allergens, exercise, NSAIDs
- β Risk factors/history β Personal or family history of atopy (eczema, rhinitis), occupational exposure (baker, welder), smoking
- β Impact + mimics β Affects sleep, work, and quality of life; mimics: COPD, GORD, heart failure, dysfunctional breathing
- β Exam findings β Expiratory polyphonic wheeze and signs of atopy (nasal polyps, eczema); may be normal between episodes
π Management
πΈKey tests:
β€ Spirometry + BDR, Fractional exhaled Nitric Oxide (FeNO), peak flow variability (2-4 weeks), blood eosinophils, CXR to exclude others
πΈLifestyle:
β€ Provide Personalised Asthma Action Plan (PAAP), advise on trigger avoidance, smoking cessation, weight management
πΈPharmacological:
β€ Adults (β₯12y): Step 1: As-needed low-dose ICS/formoterol reliever β Step 2: Low-dose ICS/formoterol MART (maintenance & reliever) β Step 3: Moderate-dose MART β Step 4: Add LTRA or LAMA (if Eosinophils or FENO: normal, Or REFER if either raised)
β€ Children (5-11y): Step 1: Low-dose ICS BD + SABA PRN β Step 2: Add LTRA for 8β12 week trial β Step 3: Stop LTRA, switch to ICS/LABA combo
β€ Children (<5y): 8-week trial of low-dose ICS; if symptoms recur, restart at low-dose; consider LTRA if poor response
πΈExacerbation/emergency:
β€ High-flow oxygen (target 94β98%), nebulised salbutamol and ipratropium bromide, oral prednisolone
πΈFollow-up/safety-net:
β€ Conduct annual asthma review, check inhaler technique and adherence, ensure annual flu/COVID-19 vaccinations
β οΈ Red Flags
β’ Life-threatening attack β PEFR <33%, SpOβ <92%, cyanosis, exhaustion, silent chest
β’ Acute severe attack β PEFR 33β50%, RR β₯25/min, HR β₯110/min, unable to complete sentences
β’ Fever with purulent sputum
β’ Unexplained weight loss or persistent hoarseness
β’ In children β Symptoms from birth, failure to thrive, excessive vomiting
β‘οΈ Referral Criteria
Urgent: Acute severe or life-threatening attacks; children with symptoms from birth, failure to thrive, or vomiting
Routine: Diagnostic uncertainty, suspected occupational asthma, poor control on Step 4 (adults) or Step 3 (children) treatment
π GP Tips
πΉPoor inhaler technique and adherence are the most common reasons for treatment failure; always check before escalating therapy
πΉAsthma is a clinical diagnosis supported by tests; normal spirometry or FeNO between attacks does not rule out the condition